The estimated Net Worth of Peter M Carlson is at least 6.08 百万$ dollars as of 10 May 2023. Mr. Carlson owns over 5,976 units of MiMedx Inc stock worth over 4,063,333$ and over the last 15 years he sold MDXG stock worth over 645,368$. In addition, he makes 1,374,220$ as Chief Financial Officer at MiMedx Inc.
Peter has made over 14 trades of the MiMedx Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 5,976 units of MDXG stock worth 35,438$ on 10 May 2023.
The largest trade he's ever made was exercising 91,625 units of MiMedx Inc stock on 12 June 2014 worth over 3,419,445$. On average, Peter trades about 4,513 units every 65 days since 2010. As of 10 May 2023 he still owns at least 656,435 units of MiMedx Inc stock.
You can see the complete history of Mr. Carlson stock trades at the bottom of the page.
Peter M. Carlson serves as Chief Financial Officer of the Company. He was appointed Chief Financial Officer in March 2020. He joined the Company as Executive Vice President - Finance in December 2019. From 2017 to 2018, Mr. Carlson served as Chief Operating Officer at Brighthouse Financial, Inc., where he helped establish the $200 billion (assets) U.S. life and annuity insurance company as a separate entity following its August 2017 spin-off from MetLife, Inc., one of the world’s leading financial services companies. He was the Chief Accounting Officer at MetLife, Inc. from 2009 to 2017 where his global responsibilities included accounting, financial planning, tax, and investment finance. Prior to joining MetLife in 2009, Carlson was the Corporate Controller at Wachovia Corporation. He currently serves as a director of White Mountains Insurance Company (NYSE: WTM). Mr. Carlson holds a Bachelor of Science from Wake Forest University and is a trustee of the university. He is licensed as a certified public accountant in North Carolina and New York.
As the Chief Financial Officer of MiMedx Inc, the total compensation of Peter Carlson at MiMedx Inc is 1,374,220$. There are 1 executives at MiMedx Inc getting paid more, with Timothy Wright having the highest compensation of 5,069,350$.
Peter Carlson is 56, he's been the Chief Financial Officer of MiMedx Inc since 2020. There are 14 older and 7 younger executives at MiMedx Inc. The oldest executive at MiMedx Group, Inc is Neil Yeston, 77, who is the Independent Director.
Peter's mailing address filed with the SEC is 1775, West Oak Commons Court Northeast, Marietta, Cobb, Georgia, 30062, United States.
Over the last 15 years, insiders at MiMedx Inc have traded over 15,165,698$ worth of MiMedx Inc stock and bought 1,553,718 units worth 4,191,559$ . The most active insiders traders include Fund Management Ltd.Okumus ...、Steve Gorlin、Parker H Petit. On average, MiMedx Inc executives and independent directors trade stock every 48 days with the average trade being worth of 487,865$. The most recent stock trade was executed by William Frank Iv Hulse on 13 March 2024, trading 20,381 units of MDXG stock currently worth 162,029$.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and burns; AmnioFix, a semi-permeable protective barrier membrane product for the treatment of wounds related to surgical procedures; EpiCord and AmnioCord that are dehydrated human umbilical cord allografts intended for homologous applications; and AmnioFill that consists of particles of connective tissue matrix derived from placental disc and placental membranes. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.
MiMedx Inc executives and other stock owners filed with the SEC include: